Asker Healthcare Group
kr 66.80Change from previous close: +0.75%Absolute change: +kr 0.50
At a glance
- Revenue growth
- +11.73%
- 2025 vs 2024
- Net income growth
- +36.67%
- 2025 vs 2024
- Net margin
- 2.9%
- 2024: 2.4%
Financial data
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 16,787 | 15,025 | 13,453 | 11,718 |
| Cost of revenue | 9,916 | 9,147 | 8,934 | 7,936 |
| Gross profit | 6,871 | 5,879 | 4,519 | 3,781 |
| Selling, general and administrative | 5,799 | 4,851 | 3,886 | 3,079 |
| Operating income | 998 | 972 | 584 | 727 |
| EBIT | 870 | 861 | 572 | 721 |
| EBITDA | 1,686 | 1,469 | 1,120 | 1,116 |
| Interest expense | 211 | 302 | 264 | 160 |
| Pre-tax income | 659 | 559 | 308 | 561 |
| Income tax | 149 | 183 | 103 | 127 |
| Net income | 492 | 360 | 203 | 430 |
| Net income to common shareholders | 492 | 360 | 203 | 430 |
| Basic EPS | 1.25 | 0.94 | 0.53 | 1.12 |
| Diluted EPS | 1.25 | 0.94 | 0.53 | 1.12 |
| Average shares (basic) | 383 | 383 | 383 | 383 |
| Average shares (diluted) | 383 | 383 | 383 | 383 |